PAYCOR HCM INC (PYCR) Stock Fundamental Analysis
NASDAQ:PYCR - Nasdaq - US70435P1021 - Common Stock - Currency: USD
We assign a fundamental rating of 3 out of 10 to PYCR. PYCR was compared to 82 industry peers in the Professional Services industry. The financial health of PYCR is average, but there are quite some concerns on its profitability. While showing a medium growth rate, PYCR is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year PYCR was profitable.
PYCR had a positive operating cash flow in the past year.
PYCR had negative earnings in each of the past 5 years.
PYCR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of -0.76%, PYCR is not doing good in the industry: 68.67% of the companies in the same industry are doing better.
PYCR has a worse Return On Equity (-1.64%) than 68.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.76% | ||
| ROE | -1.64% | ||
| ROIC | N/A |
ROA(3y)-3.25%
ROA(5y)-3.81%
ROE(3y)-7.07%
ROE(5y)-8.34%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 65.97%, PYCR is in the better half of the industry, outperforming 77.11% of the companies in the same industry.
In the last couple of years the Gross Margin of PYCR has remained more or less at the same level.
PYCR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 65.97% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.45%
GM growth 5Y1.09%
2. Health
2.1 Basic Checks
PYCR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PYCR has more shares outstanding
Compared to 5 years ago, PYCR has more shares outstanding
Compared to 1 year ago, PYCR has a worse debt to assets ratio.
2.2 Solvency
PYCR has an Altman-Z score of 1.64. This is a bad value and indicates that PYCR is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.64, PYCR is doing worse than 63.86% of the companies in the same industry.
There is no outstanding debt for PYCR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 1.64 |
ROIC/WACCN/A
WACC8.98%
2.3 Liquidity
A Current Ratio of 1.12 indicates that PYCR should not have too much problems paying its short term obligations.
PYCR has a Current ratio (1.12) which is in line with its industry peers.
A Quick Ratio of 1.12 indicates that PYCR should not have too much problems paying its short term obligations.
The Quick ratio of PYCR (1.12) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.12 | ||
| Quick Ratio | 1.12 |
3. Growth
3.1 Past
PYCR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.73%, which is quite impressive.
PYCR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.73%.
PYCR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.57% yearly.
EPS 1Y (TTM)27.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.09%
Revenue 1Y (TTM)15.73%
Revenue growth 3Y22.9%
Revenue growth 5Y17.57%
Sales Q2Q%13.1%
3.2 Future
Based on estimates for the next years, PYCR will show a very strong growth in Earnings Per Share. The EPS will grow by 21.73% on average per year.
The Revenue is expected to grow by 12.08% on average over the next years. This is quite good.
EPS Next Y18.26%
EPS Next 2Y14.99%
EPS Next 3Y16.5%
EPS Next 5Y21.73%
Revenue Next Year12.65%
Revenue Next 2Y12.05%
Revenue Next 3Y12.26%
Revenue Next 5Y12.08%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 40.16, which means the current valuation is very expensive for PYCR.
PYCR's Price/Earnings ratio is a bit more expensive when compared to the industry. PYCR is more expensive than 72.29% of the companies in the same industry.
When comparing the Price/Earnings ratio of PYCR to the average of the S&P500 Index (26.65), we can say PYCR is valued expensively.
PYCR is valuated quite expensively with a Price/Forward Earnings ratio of 34.02.
60.24% of the companies in the same industry are cheaper than PYCR, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of PYCR to the average of the S&P500 Index (21.27), we can say PYCR is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.16 | ||
| Fwd PE | 34.02 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, PYCR is valued a bit more expensive than the industry average as 71.08% of the companies are valued more cheaply.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PYCR indicates a slightly more expensive valuation: PYCR is more expensive than 65.06% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 71.33 | ||
| EV/EBITDA | 34.15 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PYCR does not grow enough to justify the current Price/Earnings ratio.
PYCR's earnings are expected to grow with 16.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.2
PEG (5Y)N/A
EPS Next 2Y14.99%
EPS Next 3Y16.5%
5. Dividend
5.1 Amount
No dividends for PYCR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
22.49
+0.04 (+0.18%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)
Earnings (Next)
Inst Owners42.91%
Inst Owner Change-4.94%
Ins Owners1.17%
Ins Owner Change-18768%
Market Cap4.09B
Analysts55.24
Price Target22.74 (1.11%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.63%
Min EPS beat(2)20.66%
Max EPS beat(2)28.59%
EPS beat(4)4
Avg EPS beat(4)17.12%
Min EPS beat(4)3.43%
Max EPS beat(4)28.59%
EPS beat(8)8
Avg EPS beat(8)25.77%
EPS beat(12)12
Avg EPS beat(12)33.54%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.55%
Min Revenue beat(2)-0.14%
Max Revenue beat(2)1.24%
Revenue beat(4)2
Avg Revenue beat(4)-0.08%
Min Revenue beat(4)-1.67%
Max Revenue beat(4)1.24%
Revenue beat(8)6
Avg Revenue beat(8)0.4%
Revenue beat(12)10
Avg Revenue beat(12)1.28%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2.79%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.07%
EPS NY rev (1m)-1.19%
EPS NY rev (3m)3.23%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.66%
Revenue NY rev (1m)0.11%
Revenue NY rev (3m)0.41%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.16 | ||
| Fwd PE | 34.02 | ||
| P/S | 5.84 | ||
| P/FCF | 71.33 | ||
| P/OCF | 34.44 | ||
| P/B | 3.12 | ||
| P/tB | 12.25 | ||
| EV/EBITDA | 34.15 |
EPS(TTM)0.56
EY2.49%
EPS(NY)0.66
Fwd EY2.94%
FCF(TTM)0.32
FCFY1.4%
OCF(TTM)0.65
OCFY2.9%
SpS3.85
BVpS7.2
TBVpS1.84
PEG (NY)2.2
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.76% | ||
| ROE | -1.64% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 65.97% | ||
| FCFM | 8.19% |
ROA(3y)-3.25%
ROA(5y)-3.81%
ROE(3y)-7.07%
ROE(5y)-8.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.45%
GM growth 5Y1.09%
F-Score6
Asset Turnover0.25
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 47.16% | ||
| Cap/Sales | 8.77% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 102.02% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.12 | ||
| Quick Ratio | 1.12 | ||
| Altman-Z | 1.64 |
F-Score6
WACC8.98%
ROIC/WACCN/A
Cap/Depr(3y)42.74%
Cap/Depr(5y)34.82%
Cap/Sales(3y)10.54%
Cap/Sales(5y)10.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.09%
EPS Next Y18.26%
EPS Next 2Y14.99%
EPS Next 3Y16.5%
EPS Next 5Y21.73%
Revenue 1Y (TTM)15.73%
Revenue growth 3Y22.9%
Revenue growth 5Y17.57%
Sales Q2Q%13.1%
Revenue Next Year12.65%
Revenue Next 2Y12.05%
Revenue Next 3Y12.26%
Revenue Next 5Y12.08%
EBIT growth 1Y83.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year128.22%
EBIT Next 3Y44.32%
EBIT Next 5Y41.74%
FCF growth 1Y324.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y383.14%
OCF growth 3Y102.92%
OCF growth 5YN/A